Summit Trail Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Summit Trail Advisors, LLC

$5.73 Billion
Q2 2025

A detailed history of Summit Trail Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 2,271 shares of REGN stock, worth $1.48 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,271

Previous 1,655 37.22%

Holding current value

$1.48 Million

Previous $1.05 Million 13.63%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$483.07 - $625.6 $297,571 - $385,369	616 Added 37.22%	2,271 $1.19 Million
Q1 2025 Apr 28, 2025	BUY	$634.14 - $744.83 $164,242 - $192,910	259 Added 18.55%	1,655 $1.05 Million
Q4 2024 Jan 29, 2025	BUY	$701.85 - $1046.91 $4,211 - $6,281	6 Added 0.43%	1,396 $994,000
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $136,203 - $159,834	133 Added 10.58%	1,390 $1.46 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $95,385 - $115,688	108 Added 9.4%	1,257 $1.32 Million
Q1 2024 Apr 23, 2024	BUY	$902.69 - $993.35 $100,198 - $110,261	111 Added 10.69%	1,149 $1.11 Million
Q4 2023 Feb 06, 2024	SELL	$775.18 - $881.7 $49,611 - $56,428	-64 Reduced 5.81%	1,038 $911,000
Q3 2023 Oct 30, 2023	BUY	$692.45 - $844.37 $26,313 - $32,086	38 Added 3.57%	1,102 $906,000
Q2 2023 Jul 25, 2023	BUY	$700.03 - $830.35 $170,807 - $202,605	244 Added 29.76%	1,064 $764,000
Q1 2023 May 04, 2023	BUY	$680.49 - $826.97 $106,836 - $129,834	157 Added 23.68%	820 $673,000
Q4 2022 Feb 07, 2023	BUY	$705.89 - $766.39 $15,529 - $16,860	22 Added 3.43%	663 $478,000
Q3 2022 Nov 09, 2022	SELL	$573.97 - $724.32 $141,770 - $178,907	-247 Reduced 27.82%	641 $442,000
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $17,547 - $23,642	32 Added 3.74%	888 $525,000
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $509,422 - $597,856	856 New	856 $598,000
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $115,525 - $134,399	-329 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$284.6 - $344.99 $47.2 Million - $57.3 Million	-166,019 Reduced 99.8%	329 $114,000
Q1 2018 May 21, 2018	BUY	$315.82 - $393.78 $52.3 Million - $65.2 Million	165,627 Added 22971.84%	166,348 $166,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $258,572 - $338,833	721	721 $275,000

Others Institutions Holding REGN

# of Institutions

1,439

Shares Held

88.9M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $69.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History